C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2004
12/14/2004	US6831060 Nucleotide sequences coding erythropoietin protein for use in the treatment of blood disorders
12/14/2004	US6831059 Compositions and methods for treating gonadotrophin related illnesses
12/14/2004	US6830937 Antibodies inhibit B-cells from binding CD28; animal immunization/vaccines; screening; fusion
12/14/2004	US6830930 Nucleic acid encoding GAI gene of arabidopsis thaliana
12/14/2004	US6830929 In vitro construction of SV40 viruses and pseudoviruses
12/14/2004	US6830924 For anticarcinogenic drugs; kits
12/14/2004	US6830921 Nucleotide sequences which code for the ACP gene
12/14/2004	US6830914 RGS-containing molecules and uses thereof
12/14/2004	US6830913 ABCB9 transporter and uses thereof
12/14/2004	US6830901 Propionibacteruim vector
12/14/2004	US6830900 Isolated human glutamate receptor DNA
12/14/2004	US6830894 Compounds and methods for modulating claudin-mediated functions
12/14/2004	US6830893 T20/DP178 is an activator of human phagocyte formyl peptide receptors
12/14/2004	US6830892 Detecting preferential viral particles in sample; obtain cell, incubate with viral nuclotide sequences, detect transduced cells, monitor cells for preferential phenotypes, detect target particles in preferential cells
12/14/2004	US6830883 Diagnosis/treatment/kits for anaemia/leukemia/immune deficiency diseases
12/14/2004	US6830749 Antitumor agents; gene therapy
12/14/2004	US6830748 Recombinant RSV virus expression systems and vaccines
12/14/2004	CA2296535C Antisense oligonucleotide inhibition of ras
12/14/2004	CA2213079C Adsorbent for tumor necrosis factor .alpha., method of removal by adsorption, and adsorption device using said adsorbent
12/14/2004	CA2180555C Radiolabeled annexins
12/14/2004	CA2169355C Tumor suppressor protein prb2, related gene products, and dna encoding therefor
12/14/2004	CA2146320C Antisense oligonucleotide inhibition of the ras gene
12/14/2004	CA2104957C Redirection of cellular immunity by receptor chimeras
12/14/2004	CA1341468C Preparation of functional human factor viii
12/09/2004	WO2004107618A2 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof
12/09/2004	WO2004106937A2 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 6 (p2y6)
12/09/2004	WO2004106936A2 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 9 (p2y9)
12/09/2004	WO2004106934A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
12/09/2004	WO2004106917A2 Method for the selection of epitopes for immunotherapy
12/09/2004	WO2004106532A1 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b
12/09/2004	WO2004106525A1 A fusion protein suitable to be expressed high effectively and the production method thereof
12/09/2004	WO2004106514A1 Method of recovering protein by deubiquitinating ubiquitinated protein
12/09/2004	WO2004106504A1 The recombinant adeno-associated viruses carrying the human gamma interferon and the metrod for preparing them
12/09/2004	WO2004106503A1 Novel il-8-like polypeptides
12/09/2004	WO2004106497A2 Imageable animal model of sars infection
12/09/2004	WO2004106378A2 Method of treating corneal transplant rejection by using vegf antagonists
12/09/2004	WO2004106374A1 Ecdysone receptor ligand-binding domain structure
12/09/2004	WO2004106373A1 Erythropoietin conjugate compounds with extended half-lives
12/09/2004	WO2004106371A1 Livin-derived peptides, compositions and uses thereof
12/09/2004	WO2004106370A1 M11l derived peptides and therapeutic use thereof
12/09/2004	WO2004106369A2 Complement inhibitors from ticks
12/09/2004	WO2004106368A1 Generation of artificial binding proteins based on ubiquitin proteins
12/09/2004	WO2004106367A2 Enterococcus antigens
12/09/2004	WO2004106364A1 Stabilizing peptides and their use in the preparation of stabilized hiv inhibitors
12/09/2004	WO2004106359A2 Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals
12/09/2004	WO2004105793A2 Soluble clca-1 and antagonists to clca-1
12/09/2004	WO2004105681A2 Cd4+ human papillomavirus (hpv) epitopes
12/09/2004	WO2004096288A3 Method of obtaining dna replication minicircles which are intended to be used for gene transfer or as immunomodulators
12/09/2004	WO2004092209A3 S. pneumoniae antigens
12/09/2004	WO2004085660A3 Improved alphavirus replicons and helper constructs
12/09/2004	WO2004085659A3 Mutant vesicular stomatitis viruses and uses thereof
12/09/2004	WO2004083436A9 Novel bt toxin receptors and methods of use
12/09/2004	WO2004081170A3 Progestin receptor-like protein
12/09/2004	WO2004076479A3 Soluble ctla4 polypeptides and methods for making the same
12/09/2004	WO2004074320A8 Therapeutic targets in cancer
12/09/2004	WO2004067725A3 Methods of identifying modulators of nmur2-mediated activity
12/09/2004	WO2004067548A3 Chemically modified metabolites of regulatory peptides and methods of producing and using same
12/09/2004	WO2004061123A3 Mbcats as modifiers of the beta-catenin pathway and methods of use
12/09/2004	WO2004060310A3 Human growth hormone crystals and methods for preparing them
12/09/2004	WO2004060262A3 Modulators of notch signalling for use in immunotherpapy
12/09/2004	WO2004050692A3 Fusion of the e2 protein of csfv with kdel , vts and/or ubiquitin for expression in transgenic plants for vaccine production
12/09/2004	WO2004046323A3 Structure of the farnesoid x receptor ligand binding domain and methods of use therefor
12/09/2004	WO2004039319A3 Novel human polypeptides encoded by polynucleotides
12/09/2004	WO2004038003A3 Human polypeptides encoded by polynucleotides and methods of their use
12/09/2004	WO2004024893A3 Nell-1 enhanced bone mineralization
12/09/2004	WO2004024873A3 CORE 1 β3-GALACTOSYLTRANSFERASE SPECIFIC MOLECULAR CHAPERONES, NUCLEIC ACIDS, AND METHODS OF USE THEREOF
12/09/2004	WO2004006866A3 Antifungal therapeutic targets
12/09/2004	WO2004003163A3 Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis
12/09/2004	WO2004003148A3 Genes encoding proteins with pesticidal activity
12/09/2004	WO2004000915A3 Silk biomaterials and methods of use thereof
12/09/2004	WO2003104258A3 Dominant gene delaying flowering
12/09/2004	WO2003101283A3 Diagnostics markers for lung cancer
12/09/2004	WO2003097790A3 Genes and uses thereof to modulate secondary metabolite biosynthesis
12/09/2004	WO2003091393A3 Nucleic “acid molecules encoding human proteins, and uses thereof”
12/09/2004	WO2003090687A8 Using heat shock proteins to increase immune response
12/09/2004	WO2003087311A3 PrLZ REGULATORY ELEMENTS IN THE TREATMENT OF DISEASE AND THE DISCOVERY OF THERAPEUTICS
12/09/2004	WO2003087136A3 Peptides derived from cadherin and methods of use thereof
12/09/2004	WO2003083076A3 Polynucleotides encoding novel two splice variants of a human cell surface protein with immunologobulin folds, bgs5g and bgs5i
12/09/2004	WO2003082898A3 Novel analogues of glucose-dependent insulinotropic polypeptide
12/09/2004	WO2003080808A3 Novel compositions and methods in cancer
12/09/2004	WO2003074726A3 Immune response associated proteins
12/09/2004	WO2003066660A3 A PAIR OF ANTIBODY Fv FRAGMENTS STABILIZED BY COILEDCOIL PEPTIDES
12/09/2004	WO2003062382A3 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals
12/09/2004	WO2003062262A3 Modulation of heat-shock-protein-based immunotherapies
12/09/2004	WO2003004687A3 Novel proteins and nucleic acids encoding same
12/09/2004	WO2003004609A3 Novel human kielin-like proteins and polynucleotides encoding the same
12/09/2004	WO2002068591A3 G-protein coupled receptor nucleic acids, polypeptides, antibodies and uses thereof
12/09/2004	WO2002044381A8 Human vno receptor (r1)
12/09/2004	US20040250313 Polypeptides for use in conferring herbicide, insect, nematode and stress tolerance in plants; altered yields; enhanced nutritional value; tissue engineering
12/09/2004	US20040250312 Transgenic plants and plant cells with reduced expression of invertase inhibitors
12/09/2004	US20040250311 AXMI-008, a delta-endotoxin gene and methods for its use
12/09/2004	US20040250310 Expression vector comprising nucleotide sequences coding insecticidal proteins for use in generating insect resistant plants; tissue engineering; biological pest control
12/09/2004	US20040250306 Transgenic rodent for use as tools in identifying modulator for treatment of diabetes, hypertension, cardiovascular and bone disorders
12/09/2004	US20040250304 Novel collagen-like protein clac, precussor thereof and genes encoding the same
12/09/2004	US20040250303 Animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy
12/09/2004	US20040250301 Transgenic animals
12/09/2004	US20040250300 Expression of proteins in milk
12/09/2004	US20040250299 Compound screening method
12/09/2004	US20040249892 Secure header information for multi-content e-mail
12/09/2004	US20040249576 Methods for rational pegylation of proteins

1 ... 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 ... 2916